David Smith / Shutterstock.com
The US Supreme Court should not review a University of Minnesota (UMN) state sovereign immunity appeal while the inter partes review (IPR) process remains shrouded in uncertainty, defendant Ericsson has claimed.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
To request a FREE 2-week trial subscription, use the same link but select the 'trial' option in the dropdown box. NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at firstname.lastname@example.org
US Supreme Court, University of Minnesota, UMN, Arthrex, US Court of Appeals for the Federal Circuit, state sovereign immunity, inter partes review, PTAB